Affymetrix, NuGen to Co-Market FFPE Sampling and GeneChip Combo | GenomeWeb
NuGen’s WT-Ovation technology will work with standard Affy 3 prime arrays, not Affy's three-inch arrays.
 
NEW YORK (GenomeWeb News) — Affymetrix today said it and NuGen Technologies will co-market a NuGen product that helps Affy GeneChip customers analyze formalin-fixed, paraffin-embedded tissue samples.
 
Affy said NuGen’s WT-Ovation technology will work with standard Affy 3 prime arrays and will allow researchers to analyze gene expression on “small and degraded” tissue samples.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.